Companies: 10,795·Total market cap: $144.5T
Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc.

ARPONASDAQHealthcare
$2.20
$-0.02(-0.90%)
Market Cap$53669220
P/E Ratio
52W High$2.3
52W Low$2.16
Overview

Aerpio Pharmaceuticals, Inc. (ARPO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ARPO · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.68arpo eps ttm · arpo earnings per shareEarnings history
PE Ratio (TTM)arpo pe ratio ttm · arpo price to earningsPE Ratio deep dive
Revenue (TTM)0.00arpo revenue ttm · arpo annual revenueFull revenue history
Dividend YieldNo Dividenddoes arpo pay dividends · arpo dividend yieldDividend history
Shares Outstanding618.9Marpo shares outstanding · arpo floatShares outstanding history
Next EarningsTBAarpo earnings date · arpo next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$7.1M▼ 72.50% YoY
202220242025
aerpio pharmaceuticals, inc. revenue · arpo revenue 2025
FY 2025Net Income-$20.6M▲ +67.66% YoY
202220242025
aerpio pharmaceuticals, inc. net income · arpo profit 2025
FY 2025EPS$-0.33▲ +86.02% YoY
202220242025
arpo eps · aerpio pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$115.8MEPS: $-1.68View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis arpo a buy · arpo analyst rating
Strong Buy
0
Buy
2
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$2.20Current
$Avg Target
$High
arpo price target · arpo 12 month forecast

Total: 4 · Buy rate: 50.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-88.34%
5Y-97.07%

About Aerpio Pharmaceuticals, Inc.

CEO
IPO DateJun 26, 2018
Employees12
CountryUS
Websiteaerpio.com

Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in Blue Ash, Ohio, currently employs 27 full-time staff. The company's core mission revolves around the research and developme…

what is aerpio pharmaceuticals, inc. · arpo stock overview · aerpio pharmaceuticals, inc. company profile · who is aerpio pharmaceuticals, inc. ceo · arpo NASDAQ · aerpio pharmaceuticals, inc. headquarters · aerpio pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Aerpio Pharmaceuticals, Inc. (ARPO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 26, 2018. As of the latest trading session, ARPO stock price is $2.20, with a market capitalization of $53.7M. The stock has returned -88.34% over the past 12 months and +0.00% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Aerpio Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Aerpio Pharmaceuticals, Inc. reported revenue of $7.1M and net income of -$20.6M. For detailed data — including Aerpio Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Aerpio Pharmaceuticals, Inc. (ARPO) stock price is $2.20. The stock is traded on NASDAQ under the ticker symbol ARPO. The 52-week range is $2.16 – $2.30.

ARPO stock priceARPO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice